Saturday, June 13, 2026
🇺🇸 FDA

pharma · Nasopharyngeal Carcinoma · Hepatocellular Carcinoma

Chinese Academy of

Xiyuan Hospital of China Academy of Chinese Medical Sciences

Chinese Academy of clinical programs — 190 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Website Investor relations
China, TAIZHOU, CN HQ
170 Employees
NMPA registrant Type
Company details
Status
Public
HQ
China, TAIZHOU, CN
Employees
170
Programs
1328
Drugs
711
Patents
335
Official website ↗ All projects Drug pipeline Patents News & analysis
Intelligence · Clinical Programs

Chinese Academy of projects

190 ClinicalTrials.gov programs sponsored by Chinese Academy of.

Chinese Academy of has 190 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

All phases Phase III Phase II Phase I NDA / BLA filed Approved programs

190 programs

Clinical programs

Page 2 of 4

  1. EVM16

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced or Recurrent Solid Tumors

    phase 1 mab active

    1 trial

  2. Engineered mitochondrial vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Advanced Solid Tumor Malignancies

    phase 1 mab active

    1 trial

  3. Ex-vivo expanded allogeneic γδ T cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    AML (Acute Myelogenous Leukemia)

    phase 1 mab active

    1 trial

  4. Ex-vivo expanded allogeneic γδT cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-Hodgkin's Lymphoma (NHL)

    phase 1 mab active

    1 trial

  5. Experimental Vaccine 1

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    COVID-19 Pneumonia

    phase 1 mab completed

    1 trial

  6. Exposure to sporting events

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronary Heart Disease

    phase 1 other completed

    1 trial

  7. FMT capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hypertension

    phase 1 mab active

    1 trial

  8. Fast Dual CAR-T Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    B-cell Lymphoma

    phase 1 mab terminated

    1 trial

  9. Fospropofol disodium

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Drug Safety

    phase 1 small molecule completed

    1 trial

  10. GC012F Injection infusion

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Idiopathic Inflammatory Myopathy (IIM)

    phase 1 small molecule active

    1 trial

  11. GPC3-CAR-T cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 1 mab on hold

    1 trial

  12. GV20-0251

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    HCC - Hepatocellular Carcinoma

    phase 1 small molecule active

    1 trial

  13. Group A

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 1 mab active

    1 trial

  14. Group A

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Colorectal Cancer

    phase 1 mab active

    1 trial

  15. HBV mRNA vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cancer

    phase 1 mab active

    1 trial

  16. HN2301 injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Systemic Lupus Erythematosus

    phase 1 small molecule active

    1 trial

  17. HN2302 Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Autoimmune Disease

    phase 1 small molecule active

    1 trial

  18. HPV-T

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Solid Tumor

    phase 1 mab active

    1 trial

  19. HQP1351ACE01

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lymphoblastic Leukemia, Acute, Childhood

    phase 1 small molecule active

    1 trial

  20. HRT, DHEA and herb

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Irregular Menses

    phase 1 small molecule completed

    1 trial

  21. Human Amniotic Epithelial Stem Cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Parkinson's Disease

    phase 1 mab completed

    1 trial

  22. Human amniotic epithelial stem cells（hAESCs）

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Graft Versus Host Disease

    phase 1 mab terminated

    1 trial

  23. Human umbilical cord mesenchymal stem cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Pneumoconiosis

    phase 1 mab active

    1 trial

  24. IASO104

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed/Refractory Multiple Myeloma (RRMM)

    phase 1 mab active

    1 trial

  25. IASO206 injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Autoimmune Hemolytic Anemia

    phase 1 mab active

    1 trial

  26. IASO206 injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed/Refractory Multiple Myeloma (RRMM)

    phase 1 small molecule active

    1 trial

  27. ICG-Cisplatin Nanoprobe (NIR-II NanoM)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Liver Cancer, Adult

    phase 1 small molecule active

    1 trial

  28. IIT2025079

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    AML - Acute Myeloid Leukemia

    phase 1 mab active

    1 trial

  29. IL-22BP mRNA vaccine injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Refractory Malignant Solid Tumors

    phase 1 mab active

    1 trial

  30. IMP3-saRNA (YMN-136) Vaccine

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non-Small Cell Lung Cancer

    phase 1 mab active

    1 trial

  31. Imatinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Solid Tumor Cancer

    phase 1 small molecule active

    1 trial

  32. Intravenous stem cell transplantation

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Stroke

    phase 1 gene therapy active

    1 trial

  33. Investigator-Selected Standard PD-1/PD-L1 Inhibitor-Based Therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Solid Tumors

    phase 1 small molecule active

    1 trial

  34. JWK002

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    X Linked Retinoschisis

    phase 1 small molecule active

    1 trial

  35. JWK007 Single intravenous infusion administration

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Duchenne Muscular Dystrophy

    phase 1 mab active

    1 trial

  36. JYEST Cell Injection Infusion

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Prevention of EBV Infection After Allogeneic Hematopoietic Stem Cell Transplantation

    phase 1 mab active

    1 trial

  37. Jianpi Qinghua granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Nonerosive Reflux Disease

    phase 1 small molecule active

    1 trial

  38. Jiedu Tongluo granules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Post-stroke Depression

    phase 1 small molecule completed

    1 trial

  39. Jiu-wei-zhen-xiao Granule

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Hepatocellular Carcinoma

    phase 1 small molecule completed

    1 trial

  40. Kang Guan Recipe (Treat)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Coronavirus Disease 2019

    phase 1 other completed

    1 trial

  41. Kukoamine B Mesilate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy

    phase 1 small molecule completed

    1 trial

  42. LCAR-AIO Cells

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Lymphocytic Leukemia

    phase 1 mab terminated

    1 trial

  43. LD and GC012F CAR-T Cell Injection

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Rheumatoid Arthritis

    phase 1 small molecule active

    1 trial

  44. LVIVO-TaVec400 product

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Multiple Myeloma (MM)

    phase 1 mab active

    1 trial

  45. Linperlisib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Relapsed/Refractory Large Granular T Lymphocytic Leukemia

    phase 1 small molecule completed

    1 trial

  46. Linperlisib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Autoimmune Hemolytic Anemia

    phase 1 small molecule terminated

    1 trial

  47. Liposomal Mitoxantrone Hydrochloride dose level 1

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Non Hodgkin Lymphoma

    phase 1 small molecule active

    1 trial

  48. Low Density Lipoprotein Receptor mRNA Exosomes

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Familial Hypercholesterolemia

    phase 1 mab active

    1 trial

Frequently asked questions

How many clinical projects does Chinese Academy of have?

190 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.